<DOC>
	<DOCNO>NCT00003422</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . It yet know whether give radiation therapy surgery effective give chemotherapy plus radiation therapy surgery treat patient rectal cancer . PURPOSE : This randomized phase III trial study radiation therapy give surgery see well work compare chemotherapy radiation therapy give surgery treat patient rectal cancer surgically remove .</brief_summary>
	<brief_title>Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery Treating Patients With Rectal Cancer That Can Be Surgically Removed</brief_title>
	<detailed_description>OBJECTIVES : - Compare local recurrence free rate quality life patient operable rectal cancer receive preoperative radiotherapy versus patient receive selective postoperative chemoradiotherapy . - Determine local recurrence free survival , overall survival , time appearance distant metastasis , disease free survival morbidity patient . OUTLINE : This randomize , multicenter study . Patients stratify number factor include surgeon . Patients randomize receive preoperative radiotherapy ( arm I ) postoperative chemoradiotherapy ( arm II ) . - Arm I : Patients receive radiotherapy 5 fraction 1 week prior surgery . Patients undergo surgery within 7 day last fraction radiotherapy . - Arm II : Patients receive chemoradiotherapy 4-12 week surgery ( circumferential resection margin histologically involved tumor ) . Radiotherapy administer 25 fraction 5 week ( 5 day per week ) . During radiotherapy , patient either receive fluorouracil ( 5-FU ) continuous infusion , 5-FU bolus IV leucovorin calcium IV weekly , 5-day bolus schedule 5-FU leucovorin calcium . Patients may receive adjuvant chemotherapy per local policy . Quality life assessment make every 3 month 1 year every 6 month next 2 year . Patients follow every 3 month 1 year , every 6 month 2 year , annually thereafter . PROJECTED ACCRUAL : Approximately 1800 patient accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm adenocarcinoma rectum ( define low edge tumor within 15 cm anal verge ) Tumor consider potentially operable No evidence metastasis indicate liver ultrasound CT scan ; chest xray ; renal , liver , bone profile PATIENT CHARACTERISTICS : Age : 75 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Cardiovascular : No uncontrolled heart failure angina Other : No concurrent uncontrolled medical illness ( e.g. , infection ) No prior concurrent malignancy likely interfere protocol treatment comparison PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>stage I rectal cancer</keyword>
	<keyword>stage II rectal cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>adenocarcinoma rectum</keyword>
</DOC>